VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats

Stock Information for VolitionRX Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About VolitionRX Limited

VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
VolitionRx Announces Acceptance of Compliance Plan by NYSE American
Volition Launches rNuQ(TM) Webshop Broadening Product Range
VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium
Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.